The 20th Anniversary of Pharmaceuticals — Multi-Targeted Natural Products as Therapeutics
| dc.contributor.editor | Enioutina, Elena Y. | |
| dc.contributor.editor | Job, Kathleen M. | |
| dc.contributor.editor | Sherwin, Catherine | |
| dc.date.accessioned | 2025-08-12T09:29:33Z | |
| dc.date.available | 2025-08-12T09:29:33Z | |
| dc.date.issued | 2025 | |
| dc.identifier | ONIX_20250812T110751_9783725837748_174 | |
| dc.identifier.uri | https://directory.doabooks.org/handle/20.500.12854/165419 | |
| dc.description.abstract | This Special Issue summarizes the latest research findings on identifying natural products targeting multiple pathways and body functions that can successfully treat multifactorial diseases. Research articles presented in this issue may be of great interest to pharmacologists, pharmacists, and physicians interested in the complementary treatment of disease. | |
| dc.language | English | |
| dc.subject.classification | thema EDItEUR::M Medicine and Nursing::MK Medical specialties, branches of medicine::MKZ Therapy and therapeutics::MKZV Gene therapy | |
| dc.subject.other | natural bioactive compounds | |
| dc.subject.other | medicinal plants | |
| dc.subject.other | vitamins | |
| dc.subject.other | minerals | |
| dc.subject.other | melatonin | |
| dc.subject.other | propolis | |
| dc.subject.other | probiotics | |
| dc.subject.other | prebiotics | |
| dc.subject.other | dosages | |
| dc.subject.other | immunomodulators | |
| dc.subject.other | antioxidants | |
| dc.subject.other | PI3K/AKT | |
| dc.subject.other | myocardial ischemic reperfusion injury | |
| dc.subject.other | phytochemicals | |
| dc.subject.other | cardiovascular disease | |
| dc.subject.other | bile acid | |
| dc.subject.other | bioactive compounds | |
| dc.subject.other | cholesterol | |
| dc.subject.other | p-coumaric acid | |
| dc.subject.other | hypericin | |
| dc.subject.other | hyperforin | |
| dc.subject.other | medicinal plant | |
| dc.subject.other | microbiota | |
| dc.subject.other | natural products | |
| dc.subject.other | ursodeoxycholic acid | |
| dc.subject.other | Vasaka | |
| dc.subject.other | TRPA1 | |
| dc.subject.other | airway epithelium | |
| dc.subject.other | mucus hypersecretion | |
| dc.subject.other | MUC5AC | |
| dc.subject.other | lung injury | |
| dc.subject.other | wood smoke | |
| dc.subject.other | biomass smoke | |
| dc.subject.other | insulin resistance | |
| dc.subject.other | type 2 diabetes | |
| dc.subject.other | natural product | |
| dc.subject.other | membrane-active immunomodulator | |
| dc.subject.other | diethyl azelate | |
| dc.subject.other | drug discovery | |
| dc.subject.other | drug development | |
| dc.subject.other | antimicrobial resistance | |
| dc.subject.other | mechanistic evidence | |
| dc.subject.other | respiratory tract infections | |
| dc.subject.other | multi-targeted | |
| dc.subject.other | allopolyherbal | |
| dc.subject.other | diabetes | |
| dc.subject.other | polyherbal | |
| dc.subject.other | streptozotocin | |
| dc.subject.other | rat | |
| dc.subject.other | in vivo | |
| dc.subject.other | So Shiho Tang | |
| dc.subject.other | chronic inflammation | |
| dc.subject.other | systemic | |
| dc.subject.other | herbal medicine | |
| dc.subject.other | multitarget | |
| dc.subject.other | biomarker | |
| dc.subject.other | antioxidant | |
| dc.subject.other | antihyperglycemic | |
| dc.subject.other | Campylanthus glaber | |
| dc.subject.other | herbal drug | |
| dc.subject.other | quality control | |
| dc.subject.other | safety | |
| dc.subject.other | verbascoside | |
| dc.subject.other | galangal–cinnamon aqueous extract | |
| dc.subject.other | SARS-CoV-2 MPro | |
| dc.subject.other | antiviral assay | |
| dc.subject.other | phenolic compounds | |
| dc.subject.other | quantum-chemical methods | |
| dc.subject.other | chicory | |
| dc.subject.other | Cichorium intybus L. | |
| dc.subject.other | multi-targeting properties | |
| dc.subject.other | hypolipidemic | |
| dc.subject.other | hypoglycemic | |
| dc.subject.other | hepatoprotective | |
| dc.subject.other | Citrus species | |
| dc.subject.other | essential oils | |
| dc.subject.other | cold press | |
| dc.subject.other | antibacterial | |
| dc.subject.other | anti-coagulant | |
| dc.subject.other | docking study | |
| dc.subject.other | ADME | |
| dc.subject.other | herbal medicinal products | |
| dc.subject.other | over-the-counter medicines | |
| dc.subject.other | children | |
| dc.subject.other | diseases | |
| dc.subject.other | childhood age | |
| dc.subject.other | ent-kauranes | |
| dc.subject.other | diterpenoids | |
| dc.subject.other | ADMET properties | |
| dc.subject.other | drug-likeness | |
| dc.subject.other | pharmacokinetics | |
| dc.subject.other | acne vulgaris | |
| dc.subject.other | case reports | |
| dc.subject.other | clinical studies | |
| dc.subject.other | dermatitis | |
| dc.subject.other | eczema | |
| dc.subject.other | efficacy | |
| dc.subject.other | essential oils (EOs) | |
| dc.subject.other | psoriasis | |
| dc.subject.other | rosacea | |
| dc.subject.other | quality | |
| dc.subject.other | tea tree oil (TTO) | |
| dc.subject.other | gambir | |
| dc.subject.other | keloid | |
| dc.subject.other | target protein | |
| dc.subject.other | molecular simulation | |
| dc.subject.other | pentacyclic triterpenes | |
| dc.subject.other | non-small cell lung carcinoma | |
| dc.subject.other | chemoresistance | |
| dc.subject.other | chicory extract | |
| dc.subject.other | male reproductive system | |
| dc.subject.other | spermatogenesis | |
| dc.subject.other | fertility | |
| dc.subject.other | offspring development | |
| dc.subject.other | CBD extracts | |
| dc.subject.other | asthma | |
| dc.subject.other | type 2 helper T cells (Th2) | |
| dc.subject.other | neutrophil | |
| dc.subject.other | eosinophil | |
| dc.subject.other | OVA-induced asthmatic mouse model | |
| dc.subject.other | cytokines | |
| dc.subject.other | migration | |
| dc.subject.other | IgE | |
| dc.subject.other | Cannabis sativa L. inflorescence extract | |
| dc.subject.other | lipopolysaccharide | |
| dc.subject.other | mast cells | |
| dc.subject.other | cytokine | |
| dc.subject.other | deep cervical lymph nodes | |
| dc.subject.other | dura mater | |
| dc.subject.other | hydrodistillation | |
| dc.subject.other | essential oil | |
| dc.subject.other | chromatographic characterization | |
| dc.subject.other | caryophyllenes | |
| dc.subject.other | leukocytes and cytokines | |
| dc.subject.other | benign prostatic hyperplasia | |
| dc.subject.other | Prunella vulgaris L. | |
| dc.subject.other | proliferation | |
| dc.subject.other | apoptosis | |
| dc.subject.other | growth factors | |
| dc.subject.other | biflavone | |
| dc.subject.other | podocarpusflavone A | |
| dc.subject.other | zebrafish | |
| dc.subject.other | tuberculosis | |
| dc.subject.other | Kielmeyera | |
| dc.subject.other | toxicity | |
| dc.subject.other | Bursera microphylla | |
| dc.subject.other | chitosan | |
| dc.subject.other | microparticles | |
| dc.subject.other | encapsulation and bioactivity | |
| dc.subject.other | natural compounds | |
| dc.subject.other | HPLC | |
| dc.subject.other | nociception | |
| dc.subject.other | anti-inflammatory | |
| dc.subject.other | mechanism of action | |
| dc.subject.other | pain | |
| dc.subject.other | n/a | |
| dc.title | The 20th Anniversary of Pharmaceuticals — Multi-Targeted Natural Products as Therapeutics | |
| dc.type | book | |
| oapen.identifier.doi | 10.3390/books978-3-7258-3773-1 | |
| oapen.relation.isPublishedBy | 46cabcaa-dd94-4bfe-87b4-55023c1b36d0 | |
| oapen.relation.isbn | 9783725837748 | |
| oapen.relation.isbn | 9783725837731 | |
| oapen.pages | 522 |
Files in this item
| Files | Size | Format | View |
|---|---|---|---|
|
There are no files associated with this item. |
|||

